After depositing saliva into a tube and applying a little heat, enzymes
and reagents react to the presence of the virus’s RNA and change the
color of the liquid from red to yellow to indicate a positive result.
(Columbia University Irving Medical Center)
"We are building a portfolio of highly relevant COVID-19 solutions
that spans diagnostics, prevention, early intervention and rescue
therapies,” said Sorrento Chairman and CEO Henry Ji.
“COVI-TRACE will be a key asset in our diagnostic solutions, and we
intend to move rapidly to submit an emergency use authorization request
to the FDA and prepare for full-scale production,” Ji said. “Such a
simple, deployable and cost-effective solution, in synergy with our
potentially neutralizing antibodies, could become the 'economy opener'
our country has been waiting for.”